Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
2025 Diseases of the Digestive System Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the digestive system ... Read More
-
Gastrointestinal Stents Market Report by Product Type (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents), Technology Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents, and Others), Material (Plastic Stents, Self-Expanding Metal Stents, Covered Self-Expandable Metallic Stents, Biodegradable or Drug Eluting Stents), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
... A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube ... Read More
-
Short Bowel Syndrome (SBS)
... 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. GLP-2 Drug Class, one of the segments analyzed in the report, is expected to record a 23.2% CAGR and reach US$5.4 Billion by ... Read More
-
Antacids
... 2.2% over the analysis period 2024-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Ulcerative Colitis Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Gastrointestinal Videoscopes
... CAGR of 6.4% over the analysis period 2024-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Digestive Enzyme Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Animal Source, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$817.7 Million by the end of ... Read More
-
Peptic Ulcer Drugs
... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Gastrointestinal Therapeutics
... CAGR of 5.1% over the analysis period 2024-2030. Crohn`s Disease End-Use, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion by the end of the ... Read More
-
Gastroparesis Drugs
... CAGR of 4.8% over the analysis period 2024-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Gastroesophageal Reflux Disease (GERD) Therapeutics
... Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Antacids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.6 Billion by ... Read More
-
Digestive Remedies in India
... of Earth Sciences, India faced one of its harshest summers on record, with over 200 heatwave days recorded across various states, therefore intensifying the risk of dehydration and heat-related illnesses. Such conditions led to heightened ... Read More
-
Consumer Health in India
... changes. Key factors contributing to growth include rising disposable incomes, urbanisation, and the increasing prevalence of dual-income households. With busier lifestyles, especially in urban settings, consumers are seeking convenient health solutions, driving demand for preventive ... Read More
-
2025 Global Forecast for Digestive Health Enzymes Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Colonoscopy Devices Market Report by Product Type (Colonoscope, Visualization Systems, and Others), Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn’s Disease, and Others), End User (Hospitals, Ambulatory Surgery Center, and Others), and Region 2025-2033
... global colonoscopy devices market size reached USD 1.70 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.52 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Digestive Remedies in Singapore
... home cooking for various reasons - whether as a hobby, a means to control expenses, or a strategy to boost health. This shift resulted in a decline in dining out, limiting the consumption of rich, ... Read More
-
2024-2029 Finland Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Vietnam Virology, Bacteriology, Parasitology and Mycology Market Database: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis ... Read More
-
2024-2029 Colombia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 Russia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
-
2024-2029 New Zealand Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, ... Read More
-
2024-2029 Slovenia Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Shares: 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Respiratory, STD, Gastrointestinal and Other Microbiology Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 major infectious disease tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: AIDS/HIV, Adenovirus, Aeromonads, ... Read More
Research Assistance
